Tyra Biosciences (TYRA) Depreciation and Depletion (2020 - 2025)
Tyra Biosciences (TYRA) reported Depreciation and Depletion of $100000.0 for Q1 2025, little changed on a YoY basis from $100000.0 in Q1 2024, and little changed quarter-over-quarter from $100000.0 in Q4 2024.
Tyra Biosciences (TYRA) Depreciation and Depletion (2020 - 2025) Analysis & Trends
Tyra Biosciences has reported Depreciation and Depletion for 6 years, with the latest figure at $100000.0 in Q1 2025.
- For the quarter ending Q1 2025, Depreciation and Depletion changed 0.0% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2025 stood at $400000.0 (changed 0.0% YoY), and the FY2024 full-year result was $500000.0, up 25.0% from the prior year.
- Depreciation and Depletion for Q1 2025 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $41.0 million in Q3 2021, with the low at -$89.9 million in Q4 2021.
- Historically, Depreciation and Depletion has averaged $23764.7 across 5 years, with a median of $100000.0 in 2022.
- The largest YoY upside for Depreciation and Depletion was 156.25% in 2021 against a maximum downside of 221.47% in 2021.
- Tyra Biosciences' Depreciation and Depletion stood at -$89.9 million in 2021, then surged by 100.11% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
- The last three Depreciation and Depletion figures came in at $100000.0 (Q1 2025), $100000.0 (Q4 2024), and $100000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Tyra Biosciences | 1.67 Bn | 1.67 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Dec 31, 2022 | 100,000.00 |